Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.17%
+6.81%
+2.00%
-7.29%
-26.16%
Most Trending
-2.17%
+6.81%
+2.00%
-7.29%
-26.16%
20 Nov 2025$EXAS stole the spotlight today, jumping 17.16% to close at a two-year high on record-breaking volume of 62.4 million shares, nearly 19 times its 30-day average. The surge comes after news that Abbott plans to complete a $21 billion M&A deal for Exact Sciences, a move that sent ripples across the healthcare and diagnostics sectors. Investors are interpreting this as a strong validation of Exact Sciences market-leading position in cancer screening and early detection technologies, highlighting the innovative edge and deep clinical expertise.
The trading action today reflects both the merger excitement and broader investor confidence in the growth potential of diagnostic services. Exact Sciences ability to scale its screening solutions, coupled with Abbott extensive commercial reach, could drive revenue growth well above its historical 20–25% annual pace. For investors, this also underscores a shift in healthcare toward preventive diagnostics and recurring revenue models, which can enhance predictability and credit quality for a company with strong fundamentals.
From a strategic perspective, Exact Sciences benefits from a differentiated product portfolio and a first-mover advantage in non-invasive cancer tests, positioning it to capture market share in a rapidly expanding diagnostics industry. Competitive barriers, including intellectual property and clinical validation, further support its premium valuation relative to peers.
Looking forward, the sustainability of this trend will depend on regulatory approvals, integration execution, and continued adoption of its core diagnostic platforms. Traders should note the potential for short-term volatility around deal finalization, but long-term investors may view today breakout as a signal of transformative growth under Abbott umbrella. Exact Sciences is clearly the Bull of the Day, offering both a near-term momentum play and a compelling story for strategic, patient capital.
Pro Members01:41 PM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Pro Members01:41 PM
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
BullPower
